Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 8/20 | 0.50 |
| ▸ | GRM5 | P41594 | 3/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 6/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2787297 | 0.91 | PGR (0.49) | PGRGRM5PIK3CDGRIN1GRIN2B | |
| SCHEMBL2785852 | 0.90 | PGR (0.41) | PGRPIK3CDEPHX2 | |
| SCHEMBL2785545 | 0.89 | PGR (0.46) | PGRGRM5PIK3CDEPHX2GRIN1 | |
| SCHEMBL2785941 | 0.86 | PGR (0.47) | PGRPIK3CD | |
| SCHEMBL2785070 | 0.85 | PGR (0.46) | PGRPIK3CD | |
| SCHEMBL2786310 | 0.85 | PGR (0.46) | PGRPIK3CDGRIN1GRIN2B | |
| SCHEMBL2785648 | 0.85 | PIK3CD (0.38) | PGRPIK3CDEPHX2GRIN1GRIN2B | |
| SCHEMBL2786323 | 0.82 | PGR (0.45) | PGRPIK3CDEPHX2GRIN1GRIN2B | |
| SCHEMBL2784455 | 0.81 | PGR (0.40) | PGRPIK3CDGRIN1GRIN2B | |
| SCHEMBL2786610 | 0.78 | HDAC1 (0.38) | PGRPIK3CDGRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2209373-A1 | N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2010-07-28 | — | — | EP | claimed |
| WO-2009045386-A1 | N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2009-04-09 | — | — | WO | claimed |